<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Pluton Biosciences, LLC

    Pluton Biosciences, LLC

    Nature is full of untapped potential. Microbes are a proven but underused resource...

    Nature is full of untapped potential. Microbes ...

    Amount Raised:    $98,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Verastem, Inc.

    Verastem, Inc.

    Verastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committ...

    Verastem Oncology (Nasdaq: VSTM) is a commercia...

    Filing Type:    PU
    PhaseBio Pharmaceuticals, Inc.

    PhaseBio Pharmaceuticals, Inc.

    PhaseBio is a clinical-stage biopharmaceutical company focused on the development ...

    PhaseBio is a clinical-stage biopharmaceutical ...

    Filing Type:    PU
    Galectin Therapeutics Inc.

    Galectin Therapeutics Inc.

    Galectin Therapeutics is a biotechnology company focused on discovery and developm...

    Galectin Therapeutics is a biotechnology compan...

    Filing Type:    PU
    CareDx, Inc.

    CareDx, Inc.

    CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics co...

    CareDx, Inc., headquartered in Brisbane, Califo...

    Filing Type:    PU
    CHF Solutions, Inc.

    CHF Solutions, Inc.

    CHF Solutions is focused on improving the quality of life for patients suffering f...

    CHF Solutions is focused on improving the quali...

    Filing Type:    PU
    LIFE RECOVERY SYSTEMS HD LLC

    LIFE RECOVERY SYSTEMS HD LLC

    Cool your patients to a target temperature of 33ÂşC in about 30 minutes with Life ...

    Cool your patients to a target temperature of 3...

    Amount Raised:    $726,600.00
    Fundraising Status:    EC
    Filing Type:    CF
    OrthoPediatrics Corp.

    OrthoPediatrics Corp.

    OrthoPediatrics currently markets greater than 30 surgical systems that serve thre...

    OrthoPediatrics currently markets greater than ...

    Filing Type:    PU
    ENDRA Life Sciences Inc.

    ENDRA Life Sciences Inc.

    ENDRA Life Sciences' mission is to bring new capabilities to ultrasound and broade...

    ENDRA Life Sciences' mission is to bring new ca...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.